bioRxiv · 10.64898/2026.04.22.719367
Targeting Gi/o-coupled GPCRs to inhibit nociceptors: insights from the serotonin receptor Htr1b and triptans
Abstract
Pain perception is initiated upon activation of nociceptors of the dorsal root ganglia (DRG) and trigeminal ganglia. We identified G protein-coupled receptors (GPCRs) expressed in CGRP+ mouse and human DRG neurons and found that agonists of several identified Gi/o-coupled and orphan GPCRs attenuated neuronal excitability. Experiments focusing on the Gi/o-coupled serotonin receptor Htr1b, which is expressed in mouse and human CGRP+ DRG neurons, revealed that Htr1b/1d agonists, the triptans sumatriptan and zolmitriptan, attenuated CGRP+ neuron excitability in vitro and exhibited analgesia across several pain models, including neuropathic pain. Conditional genetic deletion experiments showed that triptan-induced analgesia is mediated by Htr1b expressed in A-fiber mechanonociceptors. Also, triptan-associated adverse effects are partially mediated by Htr1b-independent targets. Further testing identified the GPCR Gpr19 as an additional promising target for treating pain. These findings establish a preclinical screening platform for identifying novel analgesics and reveal nociceptor GPCRs that may be targeted to treat pain.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Peng, J., Sanchez, B. T., Chirila, A. M., Zeng, X., DeLisle, M. M., Qi, L., Xiao, J., Lezgiyeva, K., Low, S. A., Woolf, C. J., Sharma, N., Ginty, D. D.. 2026-04-24. Targeting Gi/o-coupled GPCRs to inhibit nociceptors: insights from the serotonin receptor Htr1b and triptans. https://doi.org/10.64898/2026.04.22.719367
Cite the original work for its findings. Save a collection to share your selection of sources.